Financial Analysis of Selected Pharmaceutical Companies in Bangladesh

Abstract

With the rapid growth of trade, commerce and industries, the numbers of publicly traded companies are considerably increasing in Bangladesh. Pharmaceutical is an important adjunct of industrialization in the country. But the net profit of this industry has decreased for the last few years. This paper attempted to review the financial performance of this industry, to test its strengths and weaknesses. This study is based on both primary and secondary data. The collected data have been tabulated, analyzed and interpreted with the help of different financial ratios, Multivariate Discriminate Analysis (MDA) as developed by Prof. Altman and statistical tools like mean, standard deviation (SD), coefficient of variance (CV) and T-test, etc. It was observed from the study of the financial statement of the Pharmaceutical industry that the profit earning capacity, liquidity position, financial position and the performance of the most of the Pharmaceuticals are not in sound position and it was also observed that the most of the Pharmaceuticals has a lower level position of bankruptcy. The reasons behind this position of the industry are inefficiency of financial management, absence of realistic goals, strict government regulation and increased cost of raw-materials, labor and overhead. The financial performance should be improved immediately. Therefore, the appropriate authority should take measures for the removal of the above problems.